Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in cardiovascular profile among calcium antagonists.

N Taira

    The American Journal of Cardiology
    |January 30, 1987
    PubMed
    Summary

    Calcium antagonists are classified into dihydropyridines and non-dihydropyridines based on their effects. Dihydropyridines primarily cause coronary vasodilation, while non-dihydropyridines have more balanced effects on vasodilation and cardiac function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quality-of-life outcomes with pimitespib in patients with advanced gastrointestinal stromal tumor: results from the randomized, double-blind, placebo-controlled, phase III, CHAPTER-GIST-301 study.

    ESMO open·2026
    Same author

    3-O-Laurylglyceryl ascorbate reinforces skin barrier function through not only the reduction of oxidative stress but also the activation of ceramide synthesis.

    International journal of cosmetic science·2016
    Same author

    Prevalence and clinical significance of supra- or infraclavicular drainage on preoperative lymphoscintigraphy in women with breast cancer.

    Diagnostic and interventional imaging·2016
    Same author

    Successful treatment of toxoplasmic encephalitis diagnosed early by polymerase chain reaction after allogeneic hematopoietic stem cell transplantation: two case reports and review of the literature.

    Transplant infectious disease : an official journal of the Transplantation Society·2015
    Same author

    Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage.

    Cell death & disease·2014
    Same author

    Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2014

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Calcium antagonists are organic compounds with varied chemical structures.
    • Their primary actions include vasodilation and myocardial depression, but with differing potencies.

    Purpose of the Study:

    • To classify calcium antagonists into distinct groups based on their pharmacodynamic profiles.
    • To compare the potencies of coronary vasodilator effects versus negative inotropic, chronotropic, and dromotropic effects.

    Main Methods:

    • Utilized isolated, blood-perfused dog preparations: papillary muscle, sinoatrial node, and atrioventricular node.
    • Compared potencies of coronary vasodilation with negative inotropic, chronotropic, and dromotropic effects for individual agents.

    Main Results:

    • Dihydropyridines (e.g., nifedipine) are more potent coronary vasodilators than cardiac depressants.
    • Non-dihydropyridines (e.g., verapamil, diltiazem) show near equipotency in vasodilation and negative dromotropic effects, with less negative inotropic potency.
    • Non-dihydropyridines further divided: verapamil/diltiazem group show similar negative dromotropic and chronotropic effects; bepridil/MCI-176 group are less potent in negative chronotropy.

    Conclusions:

    • Calcium antagonists can be meaningfully classified into dihydropyridine and non-dihydropyridine groups based on differential potencies.
    • This classification aids in understanding the nuanced pharmacodynamic actions of various calcium antagonists.

    Related Experiment Videos